Ogita S, Tsuto T, Deguchi E, Tokiwa K, Yanagihara J, Iwai N
Division of Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Japan.
Nihon Geka Gakkai Zasshi. 1989 Sep;90(9):1389-91.
To determine a favorable treatment for lymphangiomas arising around cervico-facial region, a 10-year (1979, 1-1988, 9) experience with 58 these lesions were reviewed. Therapeutic records were divided into 3 groups according to the treatment: surgical Excision (n = 16), intralesional Bleomycin (BLM) therapy (n = 11), and intralesional OK-432 Picibanil therapy (n = 31). Complete disappearance of the lesions without serious complications was noted in 3 of 16 patients treated by surgery, in 3 of 11 patients treated by BLM therapy, and in 21 of 31 patients treated by OK-432 therapy. Serious complications such as facial nerve palsy (3), ugly scars due to repeated excision (5) and short of tongue (1) were noted in surgically treated group. In BLM and OK-432 therapy groups, only a fever of 2 to 3 days' duration and local inflammatory reaction of 3 to 5 days were noted. The results suggest that OK-432 therapy is effective for these lesions.
为确定治疗头颈部淋巴管瘤的最佳方法,回顾了1979年1月至1988年9月期间对58例此类病变的10年治疗经验。治疗记录根据治疗方法分为3组:手术切除(n = 16)、瘤内注射博来霉素(BLM)治疗(n = 11)和瘤内注射沙培林(OK - 432)治疗(n = 31)。手术治疗的16例患者中有3例病变完全消失且无严重并发症,BLM治疗的11例患者中有3例,OK - 432治疗的31例患者中有21例。手术治疗组出现了严重并发症,如面神经麻痹(3例)、因反复切除导致的难看瘢痕(5例)和舌缺损(1例)。在BLM和OK - 432治疗组中,仅出现了持续2至3天的发热和持续3至5天的局部炎症反应。结果表明,OK - 432治疗对这些病变有效。